117 related articles for article (PubMed ID: 4595027)
21. [Treatment with aspartic acid in hepatic coma caused by hyperammonemia].
Fodor O; Popescu S; Grigoraş D; Barbarino F
Med Interna (Bucur); 1968 Jul; 20(7):781-5. PubMed ID: 5685308
[No Abstract] [Full Text] [Related]
22. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis.
Huber M; Rössle M; Siegerstetter V; Ochs A; Haag K; Kist M; Blum HE
Hepatogastroenterology; 2001; 48(38):541-4. PubMed ID: 11379349
[TBL] [Abstract][Full Text] [Related]
23. [Disturbances of carbohydrate regulation in hepatic lesions].
Magnenat P
Helv Med Acta; 1970 Dec; 35(5):354-62. PubMed ID: 5501843
[No Abstract] [Full Text] [Related]
24. [Survival duration and prognosis for patients with hepatic coma].
Ufer C; Dölle W; Martini GA
Internist (Berl); 1966 Jan; 7(1):43-7. PubMed ID: 4861684
[No Abstract] [Full Text] [Related]
25. Management of hepatic encephalopathy in patients with cirrhosis.
Wright G; Jalan R
Best Pract Res Clin Gastroenterol; 2007; 21(1):95-110. PubMed ID: 17223499
[TBL] [Abstract][Full Text] [Related]
26. [Ammoniuria and its relation to hydroionic factors and to the precoma situation in liver cirrhosis: the kidney as an excretory organ of ammonia].
Barrio Gómez E; Sánchez Creus P; Gómez Pérez M; Gilsanz Rico G; Pérez Oteiza C
Rev Clin Esp; 1975 Dec; 139(6):497-504. PubMed ID: 2953
[No Abstract] [Full Text] [Related]
27. Role of a false neurotransmitter, octopamine, in the pathogenesis of hepatic and renal encephalopathy.
Lam KC; Tall AR; Goldstein GB; Mistilis SP
Scand J Gastroenterol; 1973; 8(6):465-72. PubMed ID: 4589374
[No Abstract] [Full Text] [Related]
28. Ammonium metabolism and hepatic coma.
Gabuzda GJ
Gastroenterology; 1967 Nov; 53(5):806-10. PubMed ID: 4862978
[No Abstract] [Full Text] [Related]
29. [On the release of insulin in patients with fatty liver].
Waldhäusl W; Irsigler K
Wien Klin Wochenschr; 1969 Jul; 81(29):544-6. PubMed ID: 5801626
[No Abstract] [Full Text] [Related]
30. [Controlled protein administration diet and the prevention of hepatic encephalopathy].
Strata A; Giuberti T; Magnati G; Regolisti M; Sacchini D; Fiaccadori F
Minerva Dietol Gastroenterol; 1984; 30(3):245-50. PubMed ID: 6504373
[No Abstract] [Full Text] [Related]
31. Metabolic buffers in hepatic failure.
Grossi CE; Prytz B; Rousselot LM
Surgery; 1968 Nov; 64(5):928-33. PubMed ID: 5687843
[No Abstract] [Full Text] [Related]
32. [On the therapy of liver diseases with ornithine aspartate].
Melzer H; Weber D; Wotzka R
Med Klin; 1969; 64(35):1541-4. PubMed ID: 5354488
[No Abstract] [Full Text] [Related]
33. Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response.
Rijkelijkhuizen JM; Doesburg T; Girman CJ; Mari A; Rhodes T; Gastaldelli A; Nijpels G; Dekker JM
Metabolism; 2009 Feb; 58(2):196-203. PubMed ID: 19154952
[TBL] [Abstract][Full Text] [Related]
34. [Beta-cell activity during the oral glucose tolerance test in subjects with hepatic cirrhosis].
Stufano N; Altomare E; Romano A; Vendemiale G; Albano O
Boll Soc Ital Biol Sper; 1984 Jun; 60(6):1127-32. PubMed ID: 6383429
[TBL] [Abstract][Full Text] [Related]
35. Blood ammonia level in liver cirrhosis: a conditio sine qua non to confirm hepatic encephalopathy?
Gundling F; Seidl H; Schmidt T; Schepp W
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):246-7. PubMed ID: 18301310
[No Abstract] [Full Text] [Related]
36. [Changes in carbohydrate metabolism in liver cirrhosis during glucose infusion tests].
Rogos R; Meisel B; Erler K
Z Gesamte Inn Med; 1982 Apr; 37(8):228-32. PubMed ID: 7051589
[TBL] [Abstract][Full Text] [Related]
37. [Diminished glucose tolerance and increases insulin response in cirrhosis].
Felber JP; Magnenat P; Vannotti A
Schweiz Med Wochenschr; 1967 Nov; 97(46):1537-9. PubMed ID: 5595831
[No Abstract] [Full Text] [Related]
38. Brain methanethiol and ammonia concentrations in experimental hepatic coma and coma induced by injections of various combinations of these substances.
Zieve L; Doizaki WM; Lyftogt C
J Lab Clin Med; 1984 Nov; 104(5):655-64. PubMed ID: 6491466
[TBL] [Abstract][Full Text] [Related]
39. [Impaired glucide utilization in hepatic cirrhosis].
Dzúriková V; Brixová E; Niederland TR
Cas Lek Cesk; 1971 Jul; 110(30):702-7. PubMed ID: 5564290
[No Abstract] [Full Text] [Related]
40. [Pathogenesis of portal systemic encephalopathy].
García Compeán D; Valadez Castillo R; Barragán RF
Rev Invest Clin; 1990 Jul; 42 Suppl():113-9. PubMed ID: 19256149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
